Vigabatrin for the Treatment of Cocaine Dependency

Clinical trial NCT01281202 · COMPLETED

Trial details

NCT number: NCT01281202
Sponsor: Catalyst Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Cocaine Addiction Cocaine Dependence

Start date: 2011-01-01
Primary completion: 2012-10-01
Enrollment: 207

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.